RedHill Biopharma says it’s getting good results in clinical trials using ondansetron pills to help alleviate side effects such as nausea, vomiting and diarrhea among people using the blockbuster ...

Nanoparticles enhance drug solubility, stability, and bioavailability, improving therapeutic outcomes for GI conditions like IBD through targeted delivery mechanisms. Hydrogel-based systems offer ...

Scientists headed by a team at the University of British Columbia (UBC) have developed a new approach to drug design that can deliver therapeutics directly to a specific part of the gastrointestinal ...

Here are seven gastroenterology drugs and technologies that have been approved or cleared by the FDA in the past five months: 1. Voquezna Triple Pak and Voquezna Dual Pak, which both treat ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

Ironwood Pharmaceuticals, a company whose drug research yielded a blockbuster gastrointestinal disorder drug, has struck a $1 billion deal to acquire VectivBio, a biotech whose lead program brings ...

Please provide your email address to receive an email when new articles are posted on . There were several important FDA approvals for GI conditions over the past year, including the first treatment ...

Among the most recently approved drugs for weight management, glucagon-like peptide 1 (GLP-1) agonists have garnered considerable attention; however, the effects of these drugs on the gastrointestinal ...

To avoid potentially life-threatening drug-drug interactions in patients with gastrointestinal cancers, clinicians should avoid polypharmacy, but if that is not possible, they should be on the lookout ...

What Is a GI Cocktail? A gastrointestinal (GI) cocktail is a mixture of medications used to treat indigestion (dyspepsia), as well as symptoms of gastrointestinal problems such as chest and belly pain ...